Trial Profile
Study of mitochrondrial apoptosis signaling in patients who attained and not attained complete remission after treatment with alvocidib, cytarabine and mitoxantrone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Cytarabine; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Pharmacodynamics; Therapeutic Use
- 10 Aug 2015 New trial record